AI Summary

Nuclear medicine is increasingly central to Alzheimer’s diagnosis and treatment, allowing clinicians to visualize disease‑related biological changes. Amyloid PET scans are being employed to confirm amyloid pathology and to support decisions for patients receiving anti‑amyloid therapies. Tau PET imaging adds further insight by indicating disease progression and prognosis. These imaging tools help select appropriate candidates for new drugs and monitor therapeutic response.

AI summaries can be wrong sometimes—always verify important details using the source article.